Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Scott

Showing results (301-310 of 327) with videos related to

Pageof 33
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 23, 2008
Identification of amidoheteroaryls as potent inhibitors of mutant (V600E) B-Raf kinase with in vivo activityPaul D Lyne, Brian Aquila, Donald J Cook, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
RAF isoform selectivity of MEK inhibitors and rational design of a covalent ARAF-MEK inhibitorSayan Chakraborty, Jie Jiang, Javier Vinals Camallonga, et al.
Cancer Research|March 15, 2024
A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH MedulloblastomaGrace H Hwang, Maria F Pazyra-Murphy, Hyuk-Soo Seo, et al.
Cell Chemical Biology|December 30, 2019
Exploring Targeted Degradation Strategy for Oncogenic KRAS<sup>G12C</sup>Mei Zeng, Yuan Xiong, Nozhat Safaee, et al.
Cell Chemical Biology|August 8, 2017
Potent and Selective Covalent Quinazoline Inhibitors of KRAS G12CMei Zeng, Jia Lu, Lianbo Li, et al.
Nature Chemical Biology|August 11, 2025
ZBTB11 depletion targets metabolic vulnerabilities in KRAS inhibitor-resistant PDACNathan L Tran, Jiewei Jiang, Min Ma, et al.
The Medical Journal of Australia|August 30, 2013
First hand transplant procedure in Australia: outcome at 2 yearsKaren M Dwyer, Angela R Webb, Hayley S Furniss, et al.
BMJ Open|July 1, 2024
Comparing performance of primary care clinicians in the interpretation of SPIROmetry with or without Artificial Intelligence Decision support software (SPIRO-AID): a protocol for a randomised controlled trialGillian Doe, Ethaar El-Emir, George D Edwards, et al.
Cancer Cell|March 5, 2019
Increased Serine and One-Carbon Pathway Metabolism by PKCλ/ι Deficiency Promotes Neuroendocrine Prostate CancerMiguel Reina-Campos, Juan F Linares, Angeles Duran, et al.
Molecular Cell|November 25, 2022
The miniature CRISPR-Cas12m effector binds DNA to block transcriptionWen Y Wu, Prarthana Mohanraju, Chunyu Liao, et al.
Pageof 33

Showing results (301-310 of 327) with videos related to

Sort By:
Pageof 33
Bioorganic & Medicinal Chemistry Letters|December 23, 2008
Identification of amidoheteroaryls as potent inhibitors of mutant (V600E) B-Raf kinase with in vivo activityPaul D Lyne, Brian Aquila, Donald J Cook, et al.
Biorxiv : the Preprint Server for Biology|December 25, 2025
RAF isoform selectivity of MEK inhibitors and rational design of a covalent ARAF-MEK inhibitorSayan Chakraborty, Jie Jiang, Javier Vinals Camallonga, et al.
Cancer Research|March 15, 2024
A Benzarone Derivative Inhibits EYA to Suppress Tumor Growth in SHH MedulloblastomaGrace H Hwang, Maria F Pazyra-Murphy, Hyuk-Soo Seo, et al.
Cell Chemical Biology|December 30, 2019
Exploring Targeted Degradation Strategy for Oncogenic KRAS<sup>G12C</sup>Mei Zeng, Yuan Xiong, Nozhat Safaee, et al.
Cell Chemical Biology|August 8, 2017
Potent and Selective Covalent Quinazoline Inhibitors of KRAS G12CMei Zeng, Jia Lu, Lianbo Li, et al.
Nature Chemical Biology|August 11, 2025
ZBTB11 depletion targets metabolic vulnerabilities in KRAS inhibitor-resistant PDACNathan L Tran, Jiewei Jiang, Min Ma, et al.
The Medical Journal of Australia|August 30, 2013
First hand transplant procedure in Australia: outcome at 2 yearsKaren M Dwyer, Angela R Webb, Hayley S Furniss, et al.
BMJ Open|July 1, 2024
Comparing performance of primary care clinicians in the interpretation of SPIROmetry with or without Artificial Intelligence Decision support software (SPIRO-AID): a protocol for a randomised controlled trialGillian Doe, Ethaar El-Emir, George D Edwards, et al.
Cancer Cell|March 5, 2019
Increased Serine and One-Carbon Pathway Metabolism by PKCλ/ι Deficiency Promotes Neuroendocrine Prostate CancerMiguel Reina-Campos, Juan F Linares, Angeles Duran, et al.
Molecular Cell|November 25, 2022
The miniature CRISPR-Cas12m effector binds DNA to block transcriptionWen Y Wu, Prarthana Mohanraju, Chunyu Liao, et al.
Pageof 33